Evidence map›Paper›PMID 40572639›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Survival Outcomes in Metastatic Germ Cell Tumors: A Multicenter Study from Turkey.

Gul Sema Yildiran Keskin, Ozge Yetginoglu, Sertac Vurgun, Evrican Zin Guzel, Fariz Emrah Ozkan, Mesut Yilmaz, Cem Murat Soylemez, Yesim Agyol, Sinem Akbas, Muhammed Fatih Sagiroglu and 9 more

Abstract readMulticenter Study
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Gul Sema Yildiran KeskinDepartment of Medical Oncology, Health Science University, Gulhane Research and Training Hospital, Ankara 06010, Turkey.ORCID 0000-0001-6858-6974
Ozge YetginogluDepartment of Medical Oncology, Dokuz Eylül University School of Medicine, Izmir 35210, Turkey.ORCID 0000-0002-0684-8710
Sertac VurgunDepartment of Medical Oncology, Akdeniz University School of Medicine, Antalya 07058, Turkey.ORCID 0000-0001-5326-0824
Evrican Zin GuzelDepartment of Medical Oncology, Manisa Celal Bayar University School of Medicine, Manisa 45030, Turkey.
Fariz Emrah OzkanDepartment of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar 03200, Turkey.ORCID 0000-0002-4347-0366
Mesut YilmazDepartment of Medical Oncology, Sakarya Research and Training Hospital, Sakarya 54100, Turkey.
Cem Murat SoylemezDepartment of Medical Oncology, Izmir City Hospital, İzmir 35540, Turkey.
Yesim AgyolDepartment of Medical Oncology, Marmara University School of Medicine, Istanbul 34854, Turkey.
Sinem AkbasDepartment of Medical Oncology, Koc University Hospital, Istanbul 34010, Turkey.ORCID 0000-0002-7197-211X
Muhammed Fatih SagirogluDepartment of Medical Oncology, Gaziantep City Hospital, Gaziantep 27470, Turkey.
Gizem YildirimDepartment of Medical Oncology, Health Science University, Gulhane School of Medicine, Ankara 06010, Turkey.
Huseyin Salih SemizDepartment of Medical Oncology, Dokuz Eylül University School of Medicine, Izmir 35210, Turkey.ORCID 0000-0002-7083-8517
Ali Murat TatliDepartment of Medical Oncology, Akdeniz University School of Medicine, Antalya 07058, Turkey.
Ferhat EkinciDepartment of Medical Oncology, Manisa Celal Bayar University School of Medicine, Manisa 45030, Turkey.
Ramazan CosarDepartment of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar 03200, Turkey.ORCID 0000-0002-6363-2502
Ramazan AcarDepartment of Medical Oncology, Ufuk University School of Medicine, Ankara 06510, Turkey.ORCID 0000-0002-3094-899X
Musa Baris AykanDepartment of Medical Oncology, Health Science University, Gulhane School of Medicine, Ankara 06010, Turkey.ORCID 0000-0001-7538-9119
Ismail ErturkDepartment of Medical Oncology, Health Science University, Gulhane School of Medicine, Ankara 06010, Turkey.
Nuri KaradurmusDepartment of Medical Oncology, Health Science University, Gulhane School of Medicine, Ankara 06010, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neoplasms, Germ Cell and EmbryonalTesticular NeoplasmsAdolescentAdultCisplatinCohort StudiesHumansMaleMiddle AgedRetrospective StudiesTurkeyCisplatinchemotherapyIGCCCGmetastatic germ cell tumornon-seminomaseminomatesticular cancer

Identifiers

PMID40572639
PMCPMC12194896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.